Caspe, Warlito N.

HRN: 05-13-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
CEFUROXIME 750MG (VIAL)
05/08/2022
05/15/2022
IV
1.5 Then 750ng
Q8
Soft Tissue Injury Right Foot

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Non-compliant To Guidelines